Q&A: Adaptimmune’s Elliot Norry on cell therapy

Q&A: Adaptimmune’s Elliot Norry on cell therapy

Source: 
Pharmaforum
snippet: 

Dr Elliot Norry, interim chief medical officer at Adaptimmune, discusses the unique challenges of cell therapy, from manufacturing to regulatory pathways.